Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Activation (1)
- Blood (1)
- Breast cancer (1)
- Breast tissue (1)
- Carcinogenesis (1)
-
- Case-control studies (1)
- Chrna5-chrna3-chrnb4 (1)
- Cyp2a6 (1)
- Cyp2b6 (1)
- Cytochrome p-450 cyp2b6 (1)
- Gene expression (1)
- Genes (1)
- Genetic variation (1)
- Genetics of disease (1)
- Genome-wide association studies (1)
- Genotype (1)
- Logistic models (1)
- Lung (1)
- Lung cancer risk (1)
- Lung neoplasms (1)
- Meta-analysis (1)
- Metabolic (1)
- Metabolism (1)
- Nicotiana tabacum (1)
- Nicotine (1)
- Nitrosamines (1)
- Odds ratio (1)
- Pilot projects (1)
- Risk (1)
- Risk factors (1)
Articles 1 - 2 of 2
Full-Text Articles in Medical Genetics
Cis-Eqtl-Based Trans-Ethnic Meta-Analysis Reveals Novel Genes Associated With Breast Cancer Risk, Joshua Hoffman, Rebecca Graff, Nima Emami, Caroline Tai, Michael Passarelli
Cis-Eqtl-Based Trans-Ethnic Meta-Analysis Reveals Novel Genes Associated With Breast Cancer Risk, Joshua Hoffman, Rebecca Graff, Nima Emami, Caroline Tai, Michael Passarelli
Dartmouth Scholarship
Breast cancer is the most common solid organ malignancy and the most frequent cause of cancer death among women worldwide. Previous research has yielded insights into its genetic etiology, but there remains a gap in the understanding of genetic factors that contribute to risk, and particularly in the biological mechanisms by which genetic variation modulates risk. The National Cancer Institute's "Up for a Challenge" (U4C) competition provided an opportunity to further elucidate the genetic basis of the disease. Our group leveraged the seven datasets made available by the U4C organizers and data from the publicly available UK Biobank cohort to …
Pilot Study Of Cyp2b6 Genetic Variation To Explore The Contribution Of Nitrosamine Activation To Lung Carcinogenesis, Catherine Wassenaar, Qiong Dong, Christopher Amos, Margaret Spitz, Rachel F. Tyndale
Pilot Study Of Cyp2b6 Genetic Variation To Explore The Contribution Of Nitrosamine Activation To Lung Carcinogenesis, Catherine Wassenaar, Qiong Dong, Christopher Amos, Margaret Spitz, Rachel F. Tyndale
Dartmouth Scholarship
We explored the contribution of nitrosamine metabolism to lung cancer in a pilot investigation of genetic variation in CYP2B6, a high-affinity enzymatic activator of tobacco-specific nitrosamines with a negligible role in nicotine metabolism. Previously we found that variation in CYP2A6 and CHRNA5-CHRNA3-CHRNB4 combined to increase lung cancer risk in a case-control study in European American ever-smokers (n = 860). However, these genes are involved in the pharmacology of both nicotine, through which they alter smoking behaviours, and carcinogenic nitrosamines. Herein, we separated participants by CYP2B6 genotype into a high- vs. low-risk group (*1/*1 + *1/*6 vs. *6/*6). Odds ratios estimated …